Healthcare Triangle Inc

Análisis de la acción Healthcare Triangle Inc (HCTI)

$0.844

+0.006 (+0.76%)Al cierre

Loading chart…
High
0.889
Open
0.850
VWAP
0.85
Vol
106.40K
Mkt Cap
2.90M
Low
0.830
Amount
90.91K
EV/EBITDA, TTM
-1.47

Healthcare Triangle, Inc. is a healthcare information technology company. The Company is focused on advancing industry transformation in the sectors of cloud services, data science, and professional and managed services for the electronic health record (EHR), healthcare and life sciences industries. The Company operates through three segments: Software Services, Managed Services and Support, and Corporate & others. Its Software Services segment provides strategic advisory, implementation, and development services. Its Managed Services and Support segment includes post-implementation support and cloud hosting. Its technology platforms include CloudEz, DataEz, Niyama and Readabl.AI platforms. Through its platform, solutions, and services, the Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical, and life sciences, biotech companies, and medical device manufacturers in their efforts to improve data management.

AI analysis of Healthcare Triangle Inc (HCTI)

hold

Healthcare Triangle Inc (HCTI) is currently not a good buy. The stock has experienced a staggering year-to-date decline of 97.69%, indicating significant challenges. Despite a recent revenue increase to $9.19 million in Q2 2026, the company reported a net income loss of $4.4 million in the same quarter. Additionally, the RSI is at 31.245, suggesting it is oversold, but the overall trend is still negative. The main risk is the substantial decline in stock price, which has dropped 99.35% over the past year, indicating potential instability.

Métricas de valoración

The current forward P/E ratio for Healthcare Triangle Inc (HCTI) is 0.00, compared to its 5-year average forward P/E of -1.24.

Forward P/E

Fair
5Y Average P/E
-1.24
Current P/E
0.00
Sobrevalorada
1.85
Infravalorada
-4.32

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
-0.32
Current EV/EBITDA
-1.47
Sobrevalorada
14.10
Infravalorada
-14.74

Forward P/S

Fair
5Y Average P/S
0.35
Current P/S
0.30
Sobrevalorada
0.79
Infravalorada
-0.09

Cronología de eventos

2026-07-10 (ET)

17:30:00

Selling Stockholders Plan to Sell 28M Shares of Common Stock

2026-07-06 (ET)

17:30:00

Selling Stockholders Plan to Sell 28M Shares of Common Stock

2026-04-23 (ET)

08:20:00

Healthcare Triangle Launches ZoraNex Digital Self-Care Platform

2026-04-08 (ET)

16:20:00

Healthcare Triangle's Subsidiary QuantumNexis Secures New Customers

2026-03-11 (ET)

16:20:00

Healthcare Triangle Approves $2M Share Repurchase Program

Noticias

HCTI FAQ — answered by Alphio AI

Healthcare Triangle, Inc. is a healthcare information technology company. The Company is focused on advancing industry transformation in the sectors of cloud services, data science, and professional and managed services for the electronic health record (EHR), healthcare and life sciences industries. The Company operates through three segments: Software Services, Managed Services and Support, and Corporate & others. Its Software Services segment provides strategic advisory, implementation, and development services. Its Managed Services and Support segment includes post-implementation support and cloud hosting. Its technology platforms include CloudEz, DataEz, Niyama and Readabl.AI platforms. Through its platform, solutions, and services, the Company supports healthcare delivery organizations, healthcare insurance companies, pharmaceutical, and life sciences, biotech companies, and medical device manufacturers in their efforts to improve data management. It operates in the Technology sector (SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN industry).

Healthcare Triangle Inc (HCTI) is currently not a good buy. The stock has experienced a staggering year-to-date decline of 97.69%, indicating significant challenges. Despite a recent revenue increase to $9.19 million in Q2 2026, the company reported a net income loss of $4.4 million in the same quarter. Additionally, the RSI is at 31.245, suggesting it is oversold, but the overall trend is still negative. The main risk is the substantial decline in stock price, which has dropped 99.35% over the past year, indicating potential instability.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis